Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human MEF2C Antibodies:
anti-Mouse (Murine) MEF2C Antibodies:
anti-Rat (Rattus) MEF2C Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal MEF2C Primary Antibody for WB - ABIN2780048
Shen, Kamp, Gruendling, Higgins: A bifunctional O-GlcNAc transferase governs flagellar motility through anti-repression. in Genes & development 2006
Show all 8 references for ABIN2780048
Human Polyclonal MEF2C Primary Antibody for EIA, IHC (p) - ABIN358801
Janson, Chen, Li, Leifer: Functional regulatory regions of human transcription factor MEF2C. in Brain research. Molecular brain research 2001
Show all 5 references for ABIN358801
Human Polyclonal MEF2C Primary Antibody for EIA - ABIN358292
Konig, Hinard, Arnaudeau, Holzer, Potter, Bader, Bernheim: Membrane hyperpolarization triggers myogenin and myocyte enhancer factor-2 expression during human myoblast differentiation. in The Journal of biological chemistry 2004
Show all 3 references for ABIN358292
Human Polyclonal MEF2C Primary Antibody for WB - ABIN390246
Maeda, Chapman, Stewart: Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. in The Journal of biological chemistry 2002
Show all 3 references for ABIN390246
Human Polyclonal MEF2C Primary Antibody for EIA - ABIN358333
Maeda, Gupta, Stewart: TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. in Biochemical and biophysical research communications 2002
Show all 3 references for ABIN358333
Chicken Polyclonal MEF2C Primary Antibody for WB - ABIN2774663
Nagel, Meyer, Quentmeier, Kaufmann, Drexler, MacLeod: MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. in Leukemia 2008
Mef2 (show MYEF2 Antibodies) controls skeletal muscle formation after terminal differentiation.
Our study provides new insights in MEF2C conservation and provides the first evidence of mef2cb regulation by both transcriptional and post transcriptional mechanisms.
By selectively inhibiting translational initiation of mef2ca and other mRNAs, eIF4EBP3L reprograms the translational profile of muscle, enabling it to adjust to new environmental conditions.
find no evidence that the phenotypic stability in the wild type is provided by redundancy between mef2ca and its co-ortholog mef2cb, or that it is related to the selector (homeotic) gene function of mef2ca
Mef2ca single mutants have delayed heart development, but form an apparently normal heart. Mef2cb single mutants have a functional heart and are viable adults.
Data show that mef2cb is expressed in the late ventricular region, and is necessary for late myocardial addition to the arterial pole.
the genetic interaction of Tbx5 (show TBX5 Antibodies) and Mef2c is not only required for MYH6 (show MYH6 Antibodies) expression but also essential for the early stages of heart development and survival
Mef2c and Mef2d (show MEF2D Antibodies) are required for proper cardiac gene expression.
New MEF2C mutation in MEF2C haploinsufficiency syndrome
Long non-coding RNA uc.167 influences cell proliferation, apoptosis and differentiation of P19 (show CDKN2D Antibodies) cells by regulating Mef2c.
We describe the prenatal identification of 5q14.3 duplication, including MEF2C, in a monochorionic twin pregnancy with corpus callosum anomalies, confirmed by autopsy. To the best of our knowledge, this cerebral finding has been observed for the first time in 5q14.3 duplication patients, possibly widening the neurological picture of this scarcely known syndrome. A pathogenetic role of MEF2C overexpression in brain develop
The finding of a jugular pit (show IRF6 Antibodies) in this patient facilitated the diagnosis, and he is, to our knowledge, the third case of jugular pit (show IRF6 Antibodies) in association with 5q14.3 deletion incorporating the MEF2C locus.
MiR (show MLXIP Antibodies)-135b-5p and MiR (show MLXIP Antibodies)-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C
early B cell factor-1 (EBF1 (show EBF1 Antibodies)) was identified as a co-regulator of gene expression with MEF2C.
Data show that high myocyte enhancer factor 2C (MEF2C) mRNA expression leads to overexpression of MEF2C protein, and these findings provide the rationale for therapeutic targeting of MEF2C transcriptional activation in acute myeloid leukemia (show BCL11A Antibodies).
this is the first report of a Greek-Cypriot patient with a MEF2C-related phenotype highlighting the rich variability in phenotypic expression and the ethnic diversity associated with this condition.
BCL2 (show BCL2 Antibodies) inhibitors may be a therapeutic candidate in vivo for patients with ETP-ALL with high expression levels of MEF2C.
MEF2C regulates the expression of G2/M checkpoint genes (14-3-3gamma (show YWHAG Antibodies), Gadd45b (show GADD45B Antibodies) and p21 (show CDKN1A Antibodies)) and the sub-cellular localization of CYCLIN B1 (show CCNB1 Antibodies).
The cDNA sequence was analyzed and the 5' upstream region of the mef2c gene was isolated from porcine genomic DNA.
analysis of sequence and variations of the bovine myocyte enhancer factor 2C (MEF2C) gene promoter in Bos taurus cattle
results identify a novel cooperation between MEF2 factors and NR2F2 (show NR2F2 Antibodies) in the expression of the Akr1c14 gene
We conclude that ILK (show ILK Antibodies) negatively and independently of PI3K regulated MEF2C phosphorylation activity and MCK (show CKM Antibodies) mRNA expression in C2C12 cells
Data show that three transcriptional factors Gata4 (show GATA4 Antibodies), Mef2c, and Tbx5 (show TBX5 Antibodies) (abbreviated as GMT (show GAMT Antibodies)) significantly improved murine embryonic stem cells (ESCs (show NR2E3 Antibodies)) differentiated into cardiomyocytes.
MEF2C has a role in regulating outflow tract alignment and transcriptional control of Tdgf1 (show TDGF1 Antibodies)
These findings uncover a novel role for Mef2c/d in coordinating the transcriptional network that promotes early B-cell development.
our data indicate that robust hypertrophic MEF2 activation in the heart in vivo requires a background of adiponectin (show ADIPOQ Antibodies) signaling and that adiponectin (show ADIPOQ Antibodies) signaling in primary isolated CM directly enhances MEF2 activity through activation of p38 MAPK (show MAPK14 Antibodies)
SmarcA4 (show SMARCA4 Antibodies) is required for synapse development and myocyte enhancer factor 2-mediated synapse remodeling
Our results identify novel target genes for MEF2 and define MEF2 as an important regulator of Leydig cell function and male reproduction.
this is a novel mechanism of H2S-mediated activation of MEF2C and induction of miR (show MLXIP Antibodies)-133a and inhibition of hypertrophy in HHcy cardiomyocytes.
The RBM4-MEF2C-miR-1 network constitutes a novel mechanism which programs the gene expression profile toward the development of brown adipocytes.
This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe mental retardation, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described.
myocyte-specific enhancer factor 2C
, myocyte enhancer factor 2C
, myocyte-specific enhancer factor 2C-like
, MADS box transcription enhancer factor 2, polypeptide C
, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)
, Myocyte enhancer factor 2C protein
, myocyte enhancer factor 2c